A male lion with a golden manePaxton-DigitalA company owned by Kingswell Strategic VenturesBuilt for the long term.Photo: Alexas_Fotos on Unsplash

Advertise & Subscribe

Work with Paxton-Digital

Healthcare deals, explained for executives

Paxton-Digital covers healthcare mergers and acquisitions, IPOs, funding and deal structures for the people who make and finance those decisions. Most premium deal coverage costs $399 a year or more. Paxton-Digital sits between free news and those subscriptions.

For readers

Paxton-Digital Deals Digest

$9/mo
or $89/yr · cancel anytime

A focused digest of healthcare deals: who bought whom, for how much, and what it signals. Reserve a founding seat by email; we will confirm when billing opens.

For sponsors

Sponsored webinar

From $1,500
per webinar

Present a clearly labeled session to healthcare executives and deal teams, moderated by Paxton-Digital. Topic and format agreed in advance.

Sponsored article

Request pricing
Labeled, edited to our standards

A feature written with our desk or supplied by you, labeled “Sponsored” with your name, and kept separate from our news coverage.

Our standards

  • Sponsored content is always labeled, and sponsors never review or approve our news coverage.
  • Free deal coverage stays free. Paid products add depth; they do not lock away the basics.
  • Paxton-Digital publishes business information, not legal, medical or investment advice.

Get in touch

Email us with what you want to reach or reserve, and we will reply within one business day.

Email sales@paxton-digital.com

Prices in USD. Final terms are confirmed in writing before any sponsorship runs or any subscription is billed.

Latest stories

View all
Nov 14, 2026Japan’s Emergency Cybersecurity Package: AI Defenders, Rescue Teams and the Race Against Faster AttacksAfter a wave of data breaches at major companies and agencies, Japan announced a 10 billion yen package…Nov 13, 2026Moderna’s $1.3 Billion Patent Appeal: Why Section 1498 Matters to Every Government ContractorThe Federal Circuit heard arguments on whether Moderna's COVID-19 vaccine doses were made for the government, a question…Nov 12, 2026Vantive Sells Most of Its Hemodialysis Business to Rockwell Medical: A Carve-Out Playbook for Health Care LeadersVantive agreed to divest most of its hemodialysis business, including an Italian plant, to Rockwell Medical while keeping…Nov 11, 2026Oura’s $625 Million Counsel Health Deal: Why a Smart-Ring Maker Is Buying a Care PlatformOura agreed to buy AI-native primary care startup Counsel Health for $625 million. Here is what the deal…Nov 10, 2026AstraZeneca’s Reported $10 Billion Offer for Rhythm: What a Rare-Obesity Deal Says About Pharma’s Next BetsAstraZeneca made a non-binding offer worth about $10 billion for Rhythm Pharmaceuticals, Reuters reported, a move that would…Nov 9, 2026CVS Health Plans to Split Off Its Pharmacy Chain: What Unwinding Health Care’s Biggest Vertical Bet Means for DealmakersCVS Health will separate its roughly 9,000-store pharmacy business from Aetna, Caremark and its care delivery units by…